The RUBYchip™ allows for the collection of high-resolution images of all circulating tumour cells contained in the sample directly from the chip platform which enables for the first time in the IVD industry the full automation of the method into a single processing and reading unit.
RUBYnanomed demonstrated the superior performance of the RUBYchip™ when compared to competing technologies.
The RUBYchip™ ensures the repeatability of the results, minimising inter-user and inter-laboratory variability, and ultimately offering an all-in-one solution as-a-service to hospitals and laboratories at low cost.
* the technology is currently available for research use only.
RUBYnanomed works together with world-class organisations in business, research and innovation, and healthcare services.